Chirurgische Therapie des hepatozellulären Karzinoms

Bartolozzi C, Lencioni R, Donati F, Cioni D (1999) Abdominal MR: liver and pancreas. Eur Radiol 9: 1496–1512 Bharat A, Brown DB, Crippin JS et al. (2006) Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 203: 411–420 Bismuth H, Fecteau A (1998) Kombinationstherapie in der Onkologie – das hepatocelluläre Carcinom. Chirurg 69: 360–365 Bruix J, Sherman M, Llovet JM et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 421–430 Capussotti L, Muratore A, Ferrero A et al. (2006) Randomized clinical trial of liver resection with and without hepatic pedicle clamping. Br J Surg 93: 685–689 Chang CH, Chau GY, Lui WY et al. (2004) Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 139: 320–325 Colombo M (1992) Hepatocellular carcinoma. J Hepatol 15: 225–236 Cottone M, Turri M, Caltagirone M et al. (1988) Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study. Hepatogastroenterology 35: 101–103 Curley SA, Izzo F, Gallipoli A et al. (1995) Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg 222: 375–380 Decaens T, Roudot-Thoraval F, Hadni-Bresson S et al. (2006) Impact of UCSF criteria according to pre- and post-OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl Epub ahead of print: DOI: 10.1002/lt.20884 Dohmen K (2004) Many staging systems for hepatocellular carcinoma: Evolution from Child-Pugh, Okuda to SLiDe. J Gastroenterol Hepatol 19: 1227–1232 Ebara M, Ohto M, Shinagawa T et al. (1986) Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 90: 289–298 El Gazzaz G, Wong W, El Hadary MK et al. (2000) Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma. Transpl Int 13 [Suppl 1]: S406-S409 El Serag HB, Davila JA, Petersen NJ, McGlynn KA (2003) The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139: 817–823 Farges O, Belghiti J, Kianmanesh R et al. (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237: 208–217 Figueras J, Llado L, Ruiz D et al. (2005) Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial. Ann Surg 241: 582–590 Houben KW, McCall JL (1999) Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review. Liver Transpl Surg 5: 91–95 Jones DB, Koorey DJ (1987) Screening studies and markers. Gastroenterol. Clin North Am. 16: 563–573 Kim WR, Gores GJ, Benson JT et al. (2005) Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology 129: 486–493 Liu CL, Fan ST, Cheung ST et al. (2006) Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg 244: 194–203 Liu CL, Fan ST, Lo CM et al. (2005) Safety of donor right hepatectomy without abdominal drainage: a prospective evaluation in 100 consecutive liver donors. Liver Transpl 11: 314–319 Liu CL, Fan ST, Lo CM et al. (2004) Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 239: 194–201 Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362: 1907–1917 Llovet JM, Real MI, Montana X et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734–1739 Minagawa M, Makuuchi M, Takayama T, Kokudo N (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238: 703–710 Neuhaus P, Jonas S, Bechstein WO (2000) Hepatoma of the liver – resection or transplantation? Langenbecks Arch Surg 385: 171–178 Ogata S, Belghiti J, Farges O et al. (2006) Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 93: 1091–1098 Ohwada S, Kawate S, Hamada K et al. (2006) Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg 93: 339–346 Okuda K (1992) Hepatocellular carcinoma: recent progress. Hepatology 15: 948–963 Otto G, Herber S, Heise M et al. (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12: 1260–1267 Philosophe B, Greig PD, Hemming AW et al. (1998) Surgical management of hepatocellular carcinoma: resection or transplantation? J Gastrointest Surg 2: 21–27 Porrett PM, Peterman H, Rosen M et al. (2006) Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 12: 665–673 Ren FY, Piao XX, Jin AL (2006) Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma. World J Gastroenterol 12: 4656–4659 Saeki R, Nagai H, Kaneko S et al. (2000) Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. J Hepatol 33: 99–105 Sasaki A, Iwashita Y, Shibata K et al. (2006) Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas. World J Surg 30: 1567–1578 Shao YF, Yang JM, Chau GY et al. (2006) Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Surg 191: 245–249 Soderdahl G, Backman L, Isoniemi H et al. (2006) A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma. Transpl Int 19: 288–294 Strey CW, Bechstein WO (2004) Chirurgisches Vorgehen in der Therapie des hepatozellulären- und cholangiozellulären Karzinoms. J Onkologie 07: 2–7 Tait IS, Yong SM, Cuschieri SA (2002) Laparoscopic in situ ablation of liver cancer with cryotherapy and radiofrequency ablation. Br J Surg 89: 1613–1619 The Cancer of the Liver Italian Program (CLIP) Investigators (2000) Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31: 840–845 Torzilli G, Olivari N, Moroni E et al. (2004) Contrast-enhanced intraoperative ultrasonography in surgery for hepatocellular carcinoma in cirrhosis. Liver Transpl 10: S34-S38 Wang WD, Liang LJ, Huang XQ, Yin XY (2006) Low central venous pressure reduces blood loss in hepatectomy. World J Gastroenterol 12: 935–939 Wu CC, Ho WM, Cheng SB et al. (2006) Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a „blood transfusion“-free hepatectomy. Ann Surg 243: 173–180 Yao FY, Hirose R, LaBerge JM et al. (2005) A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 11: 1505–1514